Roundtable discussion: How best to ensure daily intake of antioxidants (from the diet and supplements) that is optimal for life span, disease, and general health

Annals of the New York Academy of Sciences

Volumn 854, Issue , 1998, Pages 463-476

  Reiter, J ^a   Dreosti, I ^a   Meydani, M ^a   Joseph, J ^a   Harman, D ^a   Krinsky, N ^a   Arilar P , Jr ^a   Christen, S ^a   Linnane, A W ^a   Evans, P ^a   Rosenfeld, F L ^a   Ernster, L ^a   Nohl, H ^a   Croft, K D ^a   Hsia, C J C ^a   Curtay, J P ^a   Anderson, ^a   Singh, M A F ^a   Kitani, K ^a   Kagan, V E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FREE RADICAL; VITAMIN;

CONFERENCE PAPER; DIETARY INTAKE; HEALTH; HUMAN; LIFESPAN; OXIDATIVE STRESS; AGING; ARTICLE; CATARACT; DIET; DIET SUPPLEMENTATION; HEALTH STATUS; HEART DISEASE; INCIDENCE; LIFE EXPECTANCY; NEOPLASM; PHYSIOLOGY; PREVENTIVE MEDICINE;

AGING; ANTIOXIDANTS; CATARACT; DIET; DIETARY SUPPLEMENTS; HEALTH STATUS; HEART DISEASES; HUMANS; INCIDENCE; LIFE EXPECTANCY; NEOPLASMS; PREVENTIVE MEDICINE; VITAMINS;

EID: 0032553129     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09925.x     Document Type: Conference Paper

References (12)

1. 1 National Research Council. 1989. Recommended Dietary Allowances. 10th ed. Washington D. C.: National Academy Press.
2. 2 Meydani, M. 1995. Vitamin E. Lancet 345: 170–175.
3. 3 Stampfer, M.J., C.H. Hennekens, J.E. Manson, G.A. Colditz, B. Rosner & W.C. Willett. 1993. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328: 1444–1449.
4. 4 Gey, K.F. & P. Puska. 1989. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross‐cultural epidemiology. Ann. N.Y. Acad. Sci. 570: 268–282.
5. 5 Losonczy, K.G., T.B. Harris & R.J. Havlik. 1996. Vitamin E and vitamin C supplementation use and risk of all‐cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly. Am. J. Clin. Nutr. 64: 190–196.
6. 6 Stephens, N.G., A. Parsons, P.M. Schofield et al. 1996. Randomized, controlled trial of vitamin E in patients with coronary diease: Cambridge Heart Antioxidant Study(CHAOS). Lancet 347: 781–786.
7. 7 Meydani, S.N., M. Meydani, J.B. Blumberg et al. 1997. Vitamin E supplementation enhances in vivo immune response in healthy elderly: A dose‐response study. J. Am. Med. Assoc. 277: 1380–1386.
8. 8 Sano, M., M.S. Ernesto, R.G. Thomas et al. 1997. A controlled trial of selegiline, alpha‐tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336: 1216–1222.
9. 9 Meydani, M. 1995. Antioxidant vitamins. Fron. Clin. Nutr. 4: 7–14.
10. 10 Gey, K.F., G.B. Brubacher & H.B. Stahelin. 1987. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr. 45: 1368–1377.
11. 11 Gey, K.F., H.B. Stahelin & M. Eichholser. 1993. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Panel Prospective Study. J. Clin. Invest. 71: 3–6.
12. 12 Levine, M., C. Cnry‐Cantilena, Y. Wang et al. 1996. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 93: 3704–3709.